EL7.AI
StocksMedium•19 November 2026•
3 min read

Northern Technologies quarterly sales jump 18.6% to record despite continued loss

Key Facts

1Fourth-quarter fiscal sales rose 18.6% to a record $26.461 million.
2NTIC posted a net loss attributable to the company of $642,000, or $0.07 per diluted share, in the quarter.
3Record annual sales reached $95.982 million, up 13.9%.
4The fiscal-year gross margin fell to 35.0% from 37.6%.

Northern Technologies International Corporation, listed on Nasdaq under the ticker NTIC, reported on November 19 results for the fourth quarter and fiscal year ended August 31, 2026, posting record quarterly sales of $26.461 million. Sales rose 18.6% from the same period a year earlier, when they were $22.315 million. The growth did not translate into a net profit for the company in the quarter, however, as it posted a loss attributable to the company of $642,000, or $0.07 per diluted share. The loss in the comparable quarter of 2025 was $1.1 million, or $0.12 per share. According to a StreetInsider report published the same day, the actual per-share loss was $0.06 against analysts’ estimate of a $0.06 profit, while revenue exceeded the estimate of $24.2 million.

Sales growth extended across the full fiscal year, rising 13.9% to a record annual level of $95.982 million, from $84.234 million in fiscal 2025. The company said stronger demand and sales of ZERUST industrial and Natur-Tec products drove quarterly growth, partly offset by lower ZERUST oil and gas sales. Product-line details show mixed performance: ZERUST industrial sales rose 24.3% to $17.659 million, and Natur-Tec sales climbed 23.0% to $6.325 million. By contrast, sales of ZERUST oil and gas products fell 16.5% to $2.477 million. The figures highlight that quarterly sales growth came from industrial lines and Natur-Tec products despite weakness in the oil and gas business.

At the gross-profit level, the fiscal-year gross margin fell to 35.0% from 37.6% in the prior year, a decline of 256 basis points. The company attributed the decrease to higher costs for some raw materials, including resin and solvents, which were not fully offset by price increases. Lower prices for some Natur-Tec products and a lower-margin sales mix also weighed on the annual margin. Operating expenses as a percentage of sales improved in the quarter to 39.0% from 43.5% a year earlier, despite a 6.4% rise in absolute expenses. The company said the increase in expenses was mainly tied to marketing and sales investments in the oil and gas business, alongside employee, travel and professional-fee costs.

Income from joint ventures was an additional factor in the quarterly results, falling 27.7% to $1.567 million from $2.168 million a year earlier, a difference of $601,000. The company linked the decline to lower service fees following adjustments at EXCOR and Acobal, and to lower EXCOR profitability. Meanwhile, joint-venture sales, which are not included in NTIC’s consolidated results, totaled $25.351 million, up 4.0% from the comparable period. For the full fiscal year, results attributable to NTIC shifted to a net loss of $703,000, after net income of $18,000 in 2025. The third fiscal quarter had posted record quarterly sales of $24.216 million, with a loss attributable to the company of $263,000, compared with profit of $122,000 in the third quarter of the prior year.

Commenting on the performance, Chief Executive Gautam Ramdas said the company had seen strong global demand and record annual sales, adding: "Since taking over as CEO in September 2026, I have focused on deepening engagement with our customers." For fiscal 2027, management identified accelerating sales growth and converting it into stronger profitability as priorities, while expanding ZERUST industrial and oil and gas operations and increasing adoption of Natur-Tec solutions. On the asset front, the company signed a definitive agreement on November 3 to sell its facility in Beachwood, Ohio, for $1.1 million in cash. The agreement gives the buyer a 60-day due diligence period during which it may terminate the deal for any reason. The company expects to complete the sale in the second quarter of fiscal 2027.

Open on chart